Novartis arthritis drug fails to prove it is significantly better than rival Reuters Nov 1, 2019 Novartis said Cosentyx, when used to treat active psoriatic arthritis, "narrowly missed statistical significance for superiority"…
New data fuel hopes for broad use of Novartis psoriasis drug Usha Sharma Jun 29, 2015 Novartis is increasingly confident about the potential of its new injectable drug Cosentyx, as fresh clinical data confirms its…
Novartis Cosentyx’s first IL-17 inhibitor to receive EU approval Usha Sharma Jan 19, 2015 Cosentyx is the only biologic that can be used as first-line systemic therapy in the treatment of psoriasis and as an alternative…
